Last updated: 20 June 2022 at 4:05pm EST

James E Deerfield Mgmt Hif,... Net Worth




The estimated Net Worth of James E Deerfield Mgmt Hif,... is at least $65.5 Million dollars as of 6 June 2022. James Hif owns over 38,478 units of Mirum Pharmaceuticals Inc stock worth over $64,549,363 and over the last 2 years James sold MIRM stock worth over $962,335.

James Hif MIRM stock SEC Form 4 insiders trading

James has made over 1 trades of the Mirum Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently James sold 38,478 units of MIRM stock worth $962,335 on 6 June 2022.

The largest trade James's ever made was selling 38,478 units of Mirum Pharmaceuticals Inc stock on 6 June 2022 worth over $962,335. On average, James trades about 38,478 units every 0 days since 2022. As of 6 June 2022 James still owns at least 1,540,190 units of Mirum Pharmaceuticals Inc stock.

You can see the complete history of James Hif stock trades at the bottom of the page.



Insiders trading at Mirum Pharmaceuticals Inc

Over the last 5 years, insiders at Mirum Pharmaceuticals Inc have traded over $10,912,565 worth of Mirum Pharmaceuticals Inc stock and bought 7,735,045 units worth $117,972,829 . The most active insiders traders include Forest Baskett, Scott D Sandell, and Anthony A. Jr. Florence. On average, Mirum Pharmaceuticals Inc executives and independent directors trade stock every 24 days with the average trade being worth of $4,538,937. The most recent stock trade was executed by Patrick J Heron on 6 September 2024, trading 230 units of MIRM stock currently worth $9,563.



What does Mirum Pharmaceuticals Inc do?

mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of alagille syndrome and biliary atresia disease. the company is also develops volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. mirum pharmaceuticals, inc. was founded in 2018 and is headquartered in foster city, california.



What does Mirum Pharmaceuticals Inc's logo look like?

Mirum Pharmaceuticals Inc logo

Complete history of James Hif stock trades at Mirum Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
6 Jun 2022 James E Deerfield Mgmt Hif,...
Sale 38,478 $25.01 $962,335
6 Jun 2022
1,540,190


Mirum Pharmaceuticals Inc executives and stock owners

Mirum Pharmaceuticals Inc executives and other stock owners filed with the SEC include: